series-a
Stage
1
Investors
About
Triplebar develops an AI-powered microfluidics platform to accelerate biological research and genomic design automation, enabling rapid and cost-effective creation of functionally relevant cell datasets for applications such as biologics production and T-cell therapies.
Explore Triplebar's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.